1. Home
  2. ADMA vs PIPR Comparison

ADMA vs PIPR Comparison

Compare ADMA & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • PIPR
  • Stock Information
  • Founded
  • ADMA 2004
  • PIPR 1895
  • Country
  • ADMA United States
  • PIPR United States
  • Employees
  • ADMA N/A
  • PIPR N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • PIPR Investment Bankers/Brokers/Service
  • Sector
  • ADMA Health Care
  • PIPR Finance
  • Exchange
  • ADMA Nasdaq
  • PIPR Nasdaq
  • Market Cap
  • ADMA 5.1B
  • PIPR 4.2B
  • IPO Year
  • ADMA N/A
  • PIPR N/A
  • Fundamental
  • Price
  • ADMA $18.51
  • PIPR $301.19
  • Analyst Decision
  • ADMA Strong Buy
  • PIPR Hold
  • Analyst Count
  • ADMA 3
  • PIPR 4
  • Target Price
  • ADMA $27.67
  • PIPR $312.50
  • AVG Volume (30 Days)
  • ADMA 3.3M
  • PIPR 171.7K
  • Earning Date
  • ADMA 08-07-2025
  • PIPR 08-01-2025
  • Dividend Yield
  • ADMA N/A
  • PIPR 1.86%
  • EPS Growth
  • ADMA N/A
  • PIPR 93.72
  • EPS
  • ADMA 0.84
  • PIPR 11.46
  • Revenue
  • ADMA $459,381,000.00
  • PIPR $1,540,130,000.00
  • Revenue This Year
  • ADMA $23.35
  • PIPR $8.46
  • Revenue Next Year
  • ADMA $27.67
  • PIPR $17.89
  • P/E Ratio
  • ADMA $22.16
  • PIPR $26.31
  • Revenue Growth
  • ADMA 62.23
  • PIPR 10.55
  • 52 Week Low
  • ADMA $10.21
  • PIPR $202.91
  • 52 Week High
  • ADMA $25.67
  • PIPR $351.80
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 46.05
  • PIPR 70.29
  • Support Level
  • ADMA $17.90
  • PIPR $284.78
  • Resistance Level
  • ADMA $18.69
  • PIPR $294.98
  • Average True Range (ATR)
  • ADMA 0.62
  • PIPR 6.80
  • MACD
  • ADMA 0.10
  • PIPR 1.70
  • Stochastic Oscillator
  • ADMA 74.12
  • PIPR 97.57

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.

Share on Social Networks: